DZ Bank
ADPT icon

DZ Bank’s Adaptive Biotechnologies ADPT Stock Holding History

DZ Bank’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,391
Closed -$201K – 894
2020
Q4 		$201K Buy
3,391
+2,356
+228% +$121K ﹤0.01% 761
2020
Q3 		$50.3K Hold
1,035
– – ﹤0.01% 803
2020
Q2 		$50.1K Buy
+1,035
New +$37.7K ﹤0.01% 777

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DZ Bank's ADPT Position: Q1 2021 in Review

DZ Bank sold out of Adaptive Biotechnologies (ADPT) in Q1 2021, closing a stake of 3,391 shares — an estimated $201K sold.

DZ Bank first reported a position in ADPT in Q2 2020 and held it in 3 quarters. The position peaked at $201K in Q4 2020. 249 funds tracked by Wall St. Rank hold ADPT as of Q1 2021.

  • DZ Bank reported no remaining Adaptive Biotechnologies position as of Q1 2021 after selling out during the quarter.
  • DZ Bank sold 3,391 Adaptive Biotechnologies shares in Q1 2021, an estimated $201K.
  • DZ Bank first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 3 quarters.
  • DZ Bank's Adaptive Biotechnologies position peaked at $201K in Q4 2020.
  • 249 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2021.

Based on DZ Bank's 13F filing for Q1 2021, filed 17 May 2021.